TLR3 and breast carcinoma: In breast cancer cell lines, it has been shown that TLR3, once stimulated with its ligand Poly(I:C), leads to Stat1 phosphorylation and strong TRIF-dependent production of IFN-β, together with NF-κB activation and release of pro-apoptotic cytokines.